Related links
(PDF) PCSK9 inhibitor access barriers-issues and
Mar 29, 2017 In 2015 the US Food and Drug Administration approved both alirocumab and evolocumab for high-risk patients with familial hypercholesterolemia (
Learn more
Cigna Medicare Advantage Provider Manual-2021.
Drugs/Biologics Part B Precertification department at 888-454-0013. By faxing the Drugs/Biologics Part B Precertification department at 877-730-3858. Drugs
Learn more
Originator Biologics and Biosimilars
by N Arad Cited by 1 In Medicare, this means most biologics and biosimilars are covered under the Part B benefit, which pays for drugs that are normally given in a physicians
Learn more